A multidisciplinary approach to the control of the calcium x phosphate product in dialysis patients

Dialysis and Transplantation

Volumn 28, Issue 6, 1999, Pages 309-313

  Hoar, Stephanie ^a   Morton, A Ross ^a   Meers, Carol ^b   Mulkerns, Sharon ^b   Lawlor, Marilyn ^b   Toffelmire, Edwin B ^a,b  

^a QUEEN S UNIVERSITY   (Canada)

^b KINGSTON GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; CALCIUM; PHOSPHATE; PHOSPHATE BINDING AGENT;

CALCIFICATION; CALCIUM INTAKE; CONTROLLED STUDY; DIETARY INTAKE; DIETITIAN; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; HYPERCALCEMIA; HYPERPHOSPHATEMIA; MAJOR CLINICAL STUDY; NEPHROLOGY; PARATHYROID FUNCTION; PERITONEAL DIALYSIS; PHOSPHATE INTAKE; PRIORITY JOURNAL; REVIEW;

EID: 0033025752     PISSN: 00902934     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (11)

1. Morton AR, Hercz G. Hypercalcemia in dialysis patients: Comparison of diagnostic methods. Dial Transpl 1991; 20:661-694.
2. Angelis M, Wong LL, Myers SA, Wong LM. Calciphylaxis in patients on hemodialysis: A prevalence study. Surgery 1997; 122:1083-1090.
3. Velentzas C, Meindok H, Oreopoulos DG, et al. Visceral calcification and the Ca x P product. Adv Exp Med Biol 1978; 103:195-201.
4. Lundin AP, Adler AJ, Feinroth MV, Berlyne GM, Friedman EA. Maintenance hemodialysis: Survival beyond the first decade. J Am Med Assoc 1980; 244:38-40.
5. Block GA, Hulbert-Shearon TE, Levin NW, Port FK. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: A national study. Am J Kid Dis 1998; 31:607-617.
6. Blumenkrantz MJ, Kopple JD, Moran JK, Coburn JW. Metabolic balance studies and dietary protein requirements in patients undergoing continuous ambulatory peritoneal dialysis. Kidney Int 1982; 21:849-861.
7. Cannata JB, Briggs JD, Fell GS, Junor BJR. Comparison of control of serum phosphate levels during continuous ambulatory peritoneal dialysis and during hemodialysis. Perit Dial Bull 1983; 3:81-86.
8. Sherrard DJ, Hercz G, Pei Y, et al. The spectrum of bone disease in end-stage renal failure: An evolving disorder. Kidney Int 1993; 43:436-442.
9. Ibels LS. The pathogenesis of metastatic calcification in uremia. Prog Biochem Pharmacol 1980; 17:242-50.
10. Nordin BEC. Primary and secondary hyperparathyroidism. Adv Int Med 1958; 11:81.
11. Nordin BEC. Hyperparathyroidism, Osteomalacia and Osteoporosis. In: Clinical Endocrinology, Astwood EB (ed.). New York: Grune & Straton. D&T